Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9971932 | 0.96 | SIGMAR1 (0.38) | SIGMAR1L3MBTL1CYP1A2ALDH1A1CA12 | |
| SCHEMBL14867174 | 0.96 | SIGMAR1 (0.35) | SIGMAR1L3MBTL1ALDH1A1CA12CA1 | |
| SCHEMBL14867161 | 0.88 | SIGMAR1 (0.40) | SIGMAR1L3MBTL1CYP1A2CYP3A4KDM4E | |
| SCHEMBL14867156 | 0.87 | MCL1 (0.42) | SIGMAR1CYP1A2CYP2C9CYP2C19CA12 | |
| SCHEMBL21031612 | 0.87 | SIGMAR1 (0.40) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL15294240 | 0.87 | SIGMAR1 (0.40) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL17426579 | 0.87 | SIGMAR1 (0.40) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19799381 | 0.86 | SIGMAR1 (0.36) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL12153412 | 0.86 | SIGMAR1 (0.38) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13854535 | 0.85 | SIGMAR1 (0.41) | SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | SIGMAR1 966/4885L3MBTL1 283/4885CYP1A2 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.